Navigation Links
FDA Approves New HIV Treatment
Date:5/20/2011

py. In addition, persons who failed therapy with Edurant developed more drug resistance than patients who failed efavirenz.

The most commonly reported side effects in patients taking Edurant included depression, difficulty sleeping (insomnia), headache and rash. Fewer patients stopped taking the drug due to side effects as compared to patients taking efavirenz.

Edurant does not cure HIV infection. Patients must stay on continuous HIV therapy to control HIV infection and decrease HIV-related illnesses.

Edurant is manufactured by Raritan, N.J.-based Tibotec Therapeutics, a division of Centocor Ortho Biotech Inc.

For more information:

FDA: HIV and AIDS Activities

http://www.fda.gov/ForConsumers/byAudience/ForPatientAdvocates/HIVandAIDSActivities/default.htm

FDA: Antiretroviral drugs used in the treatment of HIV infection

http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm118915.htm

CDC: HIV/AIDS

http://www.cdc.gov/hiv/default.htm

HHS: AIDS News and Resources

http://www.aids.gov/

AIDS Information

http://www.aidsinfo.nih.gov/

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

<
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Ironshore Pharmaceuticals & Development, Inc. ("Ironshore") ... company specializing in personalized medicine, to participate in ... to evaluate the safety and efficacy of HLD-200, ... disorder (ADHD). This is Restore,s second clinical trial ... partnered with Ironshore in 2014 and continues to ...
(Date:8/3/2015)... 2015  Luminex Corporation (NASDAQ: LMNX ) today ... 30, 2015.  Financial and operating highlights for the quarter ... 2015 revenue by 6 percent to $58.9 million, over ... quarter 2015 assay revenue by 22 percent to $24.2 ... , Increased Q2 2015 royalty revenue by 17 ...
(Date:8/3/2015)... -- DURECT Corporation (Nasdaq: DRRX ) announced today financial results ... million and net loss was $5.5 million for the three ... of $4.6 million and net loss of $5.5 million for ... we had cash and investments of $37.8 million, compared to ... At June 30, 2015, we had $19.8 million in long ...
Breaking Medicine Technology:Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10
... 31st European Cystic Fibrosis Conference -, SOUTH ... /PRNewswire/,-- PTC Therapeutics, Inc. (PTC) today announced promising ... fibrosis (CF). Results from an Israeli Phase 2a,extension ... in adult,patients with nonsense-mutation-mediated CF demonstrated statistically,significant improvements ...
... Data from Positive Phase 2a Trial, WALTHAM, ... ) today announced that based on feedback from ... initiate a Phase 2b clinical,trial of RG2417, an ... later this year. This will be a multi-center, ...
Cached Medicine Technology:PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 2PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 3PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 4PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 5Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 2Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 3Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 4Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder 5
(Date:8/4/2015)... ... August 04, 2015 , ... It’s been called “cosmetics heaven,” “mecca for make-up,” ... Naimie’s Beauty Center in LA. Now MENAJI is part of that experience acting as ... Beauty Center has been a favorite of makeup artists and hair pros as well ...
(Date:8/4/2015)... Port Washington, NY (PRWEB) , ... August 04, ... ... the 2015 Midyear Channel Report, finds the North America IT reseller channel will ... and profitability at rates ahead of their 2014 pace and greater than their ...
(Date:8/4/2015)... ... August 04, 2015 , ... Data2Life , a ... designed to provide pharmaceutical and healthcare organizations with advanced intelligence on drug effects. ... from regulatory filings (including the FDA and HealthCanada), social media and anonymized clinical ...
(Date:8/4/2015)... New York, NY (PRWEB) , ... August 04, ... ... FHA multifamily mortgage lender specializing in healthcare finance, announced the closing of a ... operates a two campus health system located in Smithfield and Clayton, North Carolina. ...
(Date:8/4/2015)... DC (PRWEB) , ... August 04, 2015 , ... Updated ... Inc.’s (AIS) in-house research team, can now be accessed at http://www.AISHealth.com . The ... AIS’s Directory of Health Plans: 2015, the tables and charts on the website’s “Data” ...
Breaking Medicine News(10 mins):Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2
... 13 Abbott announced new data from,the open-label ... and Safety in AS) phase III clinical trial, ... of ankylosing,spondylitis (AS) for up to three years ... is a type of arthritis that primarily causes,inflammation ...
... - June 13, 2008 - UT Southwestern Medical ... weight-loss surgery in Texas. , Rather than the ... gastric banding surgery, surgeons used a single 8-centimeter ... "There,s a current revolution in minimally invasive surgery: ...
... of Mesothelioma Victim Will Address Effort to Find ... Lexi,Miletto, whose grandfather, Joseph Miletto died in 2005 ... the Gala Dinner on Friday,evening, June 27th, part ... Malignant Mesothelioma, which runs Thursday,June 26th through Saturday, ...
... Health System to Use Valuable Patient Care,Resources in Manner ... Hundreds of Healthcare,workers from Los Angeles and Orange ... & Lardner, LLP on Thursday, June 12th to protest ... at St. Joseph Health System (SJHS), a $3.4 billion ...
... State Projected to Lose $6.2 Million in Economic ... 12 As Congress returned to,Washington this week ... Health Care Association (NHCA) released a new analysis ... A national,nursing home funding cuts will not only ...
... Dismayed by Senate Vote to Block Medicare Improvement ... for Prevention, Mental,Health and Low-Income Programs, Boosted Quality ... a minority of the,U.S. Senate blocked critical legislation ... Americans who depend on it. The Medicare Improvements,for ...
Cached Medicine News:Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 2Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 3Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 4Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 5Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 6Health News:UT Southwestern surgeons complete first single-incision lap-band surgery in Texas 2Health News:Asbestos Tragedy and Hope 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 3Health News:New NV Economic Study: Bush Medicare Cuts Undermine State and Local Economic, Jobs Base 2Health News:New NV Economic Study: Bush Medicare Cuts Undermine State and Local Economic, Jobs Base 3Health News:AARP Georgia Key Vote News Alert 2Health News:AARP Georgia Key Vote News Alert 3
... gives you an entirely new way to visualize, ... DVR is the perfect tool for turning real-life ... and footswitch, you can record only the parts ... hours of reviewing video tapes. With your finished ...
LCD monitors....
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty....
A lower cost alternative to the flagship A3, the A1 retains the essential characteristics of high quality image, simplicity of operation and reliability....
Medicine Products: